Genelux Competitors and Similar CompaniesClear all

Remedy Plan's competitors and similar companies include ABL Bio and Alchemab Therapeutics.
Remedy Plan
Remedy Plan
Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.
ABL Bio
ABL Bio
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
Alchemab Therapeutics
Alchemab Therapeutics
Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.
Founding Date
Founding Date
2011
Founding Date
2016
Founding Date
2019
Type
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
HQ
Locations
HQ
Locations
London, GB HQ
Babraham, GB
Employees
Employees
15
Employees
615% increase
Employees
512% decrease

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 65m (almost 8 years ago)
Latest funding round
$ 71.8m (about 5 years ago)
Total funding raised
Total funding raised
$ 10.1m
Total funding raised
$ 90.8m
Total funding raised
$ 71.8m
For sources of this data, please see the company profile

View Company Profiles

ABL Bio
HQ
Employees
61↑ 5% increase

ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.

View company
Alchemab Therapeutics
HQ
London, GB
Employees
51↓ 2% decrease

Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.

View company